Patent ID: 8148059
Filing Date: 2012-04-03
Classification: C12Q,G01N

Abstract:
1. A method of detecting malignancy of nasopharyngeal carcinoma, comprising steps: obtaining a blood specimen from a testee; quantitatively measuring a macrophage inflammatory protein 3α (MIP-3α) expression level of said blood specimen; and comparing said MIP-3α expression level of said blood specimen with a MIP-3α expression level of at least one control, wherein said control is a healthy subject without nasopharyngeal carcinoma; and detecting a presence level malignancy of nasopharyngeal carcinoma in said testee according to said MIP-3α expression level of said specimen and said control, wherein if the MIP-3α expression level of said specimen is higher than said control, the testee is determined to have nasopharyngeal carcinoma or have probability of metastasis of nasopharyngeal carcinoma.